Costo Utilidad de Colágena Polivinil-Pirrolidona en el Tratamiento de Osteartrosis de Rodilla en México Ximena Burbano-Levy, MD, Diana Cardona QF, PhD, Elsa Palacios Act, Israel Rico Alba, MD, PhD, León Zapata QF Value in Health Regional Issues Volume 5, Pages 40-47 (December 2014) DOI: 10.1016/j.vhri.2014.06.006 Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
Fig. 1 Modelo de Markov – Estados de Transición. OAR, osteo artrosis de rodilla. Value in Health Regional Issues 2014 5, 40-47DOI: (10.1016/j.vhri.2014.06.006) Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
Fig. 2 Análisis de Sensibilidad – Diagrama de tornado para la RCUI. CPVP, colágena polivinilpirrolidona; RCUI, costo utilidad incremental. Value in Health Regional Issues 2014 5, 40-47DOI: (10.1016/j.vhri.2014.06.006) Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
Fig. 3 RCUI: Análisis de Sensibilidad Probabilístico. RCUI, costo utilidad incremental. Value in Health Regional Issues 2014 5, 40-47DOI: (10.1016/j.vhri.2014.06.006) Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions